pronase
Biologicalexperimental
Pronase is a commercially available mixture of proteases isolated from the extracellular fluid of Streptomyces griseus. Activity extends to both denatured and native proteins leading to complete or nearly complete digestion into individual amino acids. — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2014 (NCT02030769)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPronase ↗
- ChEMBLCHEMBL2108476 ↗
Also known as
- pronase
- pronase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05249933 | Phase 2/Phase 3 (Phase 3) | Feb 24, 2021 | Changhai Hospital |
| NCT02846155 | Phase 2 | May 1, 2016 | Changhai Hospital |
| NCT02030769 | N/A | Jan 1, 2014 | Beijing Tide Pharmaceutical Co., Ltd, People's Liberation Army of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Changhai Hospital | Academic/Hospital | 2 | 2 | 2 | 2016 |
| Beijing Tide Pharmaceutical Co., Ltd | For profit | 1 | 0 | 1 | 2014 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1